Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Uterine Cancer Risk Reducing Strategies in Postmenopausal Women
NCT05651282Phase 4Completed
- Sponsor
- University of British Columbia
- Start
- Mar 2023
- Primary completion
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of medroxyprogesterone acetate in endometrial cancer (EC), sponsored by University of British Columbia. Started Mar 2023; status: completed.
02
Drugs
medroxyprogesterone acetate
03
Conditions
endometrial cancer (EC)
Beyond the preview
Go deeper on NCT05651282.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05651282.